Industrial exposure to gases and fumes may produce a wide variety of respiratory damage including tracheobronchial inflammation and parenchymal damage.' Tracheobronchial inflammation is reported, particularly after exposure to chlorine, ammonia, and sulphur dioxide. Interstitial pneumonitis has been associated with the inhalation of oxides of nitrogen,2 cadmium,3 manganese,4 mercury,5 and resins containing trimellitic anhydride. 6 We report a patient who developed both reversible airways obstruction and steroid responsive interstitial pneumonitis after accidental exposure to glacial acetic acid.
Case report
A male 37 year old maintenance fitter was exposed to a blow back of glacial acetic acid in a petrochemical works. Immediate aid was given but first degree burns of the face and arms quickly occurred. Over the next seven days he developed progressive exertional dyspnoea, limiting him to walking quietly on the flat. He had no prior respiratory illness, was a non-smoker, and there was no family history of asthma. On examination there was evidence of burns to the face and arms and inspiratory basal crackles. Routine haematology and biochemistry test results were normal. Chest radiograph showed patchy bilateral reticulonodular infliltration dominantly of the bases. No improvement occurred over the next three months and on referral to our unit he was found to be moderately dyspnoeic at rest and there were persistent extensive crackles in the basal areas of his lungs with bilateral scattered wheeze. The chest radiograph showed little change and physiology showed FEV, 1 65 (pred 3 69) and FVC 2-0 (pred 4-62) litres. TLCo was 18 ml/min/mm Hg. Bronchoscopy showed widespread bronchial inflammatory changes and bronchopulmonary lavage showed macrophages 3-28 x 106, lymphocytes 168 x 10 o, and red blood cell count 1-41 x I07. These results show a doubling of Accepted 2 November 1987 macrophages and a tenfold increase in lymphocytes which were 34% of the total inflammatory cells. Transbronchial biopsy showed a diffuse, moderate mainly mononuclear, interstitial pneumonitis. The patient was treated with high dose nebulised bronchodilators and corticosteroids. There was a prompt and sustained improvement in spirometry and clearing of his chest radiograph. Progress has been maintained at 18 months.
Discussion
Glacial acetic acid is highly irritant to the skin and mucous membrane and inhalation of the vapour results in acute tracheobronchitis. The long term effect is unknown as the vapour becomes intolerable to inhale, long before dangerous concentrations are reached, making the hazard negligible under normal conditions.7 Our patient's accident happened while he was disconnecting a pressurised pump containing hot glacial acetic acid for overhaul. It fractured coating his face and he inhaled a large cloud ofhot acetic acid as it vapourised.
Diffuse alveolar damage results when a noxious agent damages the bronchoalveolar lining cells and endothelial cells of the lung.8 The outcome of the reaction is dependent on the intensity and duration of exposure and varies from death in acute phase to resolution or interstitial fibrosis or obliterative bronchiolitis, or both, Matthes et al found diffuse tracheobronchitis and acute pneumonitis in their fatal cases of mercury vapour inhalation9 and Beton et al reported congestion of the lungs with severe haemorrhagic pneumonitis in five cases ofacute cadmium fume poisoning.'°T he course of the disease varies with the intensity of exposure, chemical nature of the agent, and the interval between the exposure and start of treatment.45 Apart from general supportive measures, oxygen, antibiotics for secondary infection, bronchodilators, and steroids have been recommended in acute pneumonitis with varying degree of response. Our patient showed a satisfactory response to steroids and 68 the lymphocytic dominance of his bronchopulmonary lavage cells suggests that the pneumonitis in the chronic phase may have an immunological basis.
